Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07681050 · ClinicalTrials.gov registry record · Phase 2
Phosphate in Acute Pancreatitis
A Phase 2 study, sponsored by Duke University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT07681050 is a Phase 2 study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 100 participants.
The verdict
NCT07681050, a Phase 2 study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to learn if phosphate administration works to treat acute pancreatitis in adults presenting to the emergency department at Duke University Hospital. The main questions it aims to answer are: * Does having low phosphate levels increase the risk of acute pancreatitis and can giving phosphate through an IV make the illness less severe? * Is phosphate therapy practical to use, and what is the appropriate dose? * Is this study achievable, and how can the results help design a future randomized controlled trial to assess safety and effectiveness? Participants will: * Receive standard of care or intravenous (IV) phosphate during their hospital stay * Have blood samples collected during admission to monitor phosphorus levels * Complete follow-up assessments after hospital admission to evaluate how severe the illness is and the effects of phosphate supplementation
Interventions
- DRUG Sodium Phosphate
- DRUG Potassium Phosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07681050
The ClinicalTrials.gov registry entry for NCT07681050 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Phosphate is the first listed.
NCT07681050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07681050 about?
NCT07681050 is a clinical study titled "Phosphate in Acute Pancreatitis". The goal of this study is to learn if phosphate administration works to treat acute pancreatitis in adults presenting to the emergency department at Duke University Hospital. The main questions it aims to answer are: * Does having low phosphate levels increase the risk of acute pancreatitis and can...
What is the current status of trial NCT07681050?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2029-01.
What interventions are being tested in trial NCT07681050?
The interventions under investigation include: Sodium Phosphate (DRUG), Potassium Phosphate (DRUG).
Who is sponsoring clinical trial NCT07681050?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.